Risto Pirinen

1.4k total citations
31 papers, 1.1k citations indexed

About

Risto Pirinen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Risto Pirinen has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Risto Pirinen's work include Proteoglycans and glycosaminoglycans research (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Peptidase Inhibition and Analysis (7 papers). Risto Pirinen is often cited by papers focused on Proteoglycans and glycosaminoglycans research (10 papers), Glycosylation and Glycoproteins Research (7 papers) and Peptidase Inhibition and Analysis (7 papers). Risto Pirinen collaborates with scholars based in Finland, Germany and Japan. Risto Pirinen's co-authors include Veli‐Matti Kosma, Risto Johansson, Markku Tammi, Raija Tammi, Jan Böhm, Päivi Auvinen, Anne Kultti, Kirsi Ropponen, E. Kumpulainen and Pasi Hirvikoski and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Risto Pirinen

31 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Risto Pirinen Finland 18 686 465 345 228 156 31 1.1k
M. Noguchi Japan 11 672 1.0× 183 0.4× 262 0.8× 126 0.6× 105 0.7× 20 969
Jason J. Zoeller United States 15 619 0.9× 370 0.8× 205 0.6× 200 0.9× 47 0.3× 23 1.1k
Karen Sisley United Kingdom 20 623 0.9× 183 0.4× 572 1.7× 190 0.8× 130 0.8× 60 1.4k
Mirva Söderström Finland 18 454 0.7× 142 0.3× 223 0.6× 256 1.1× 174 1.1× 36 903
Mumtaz V. Rojiani United States 14 537 0.8× 161 0.3× 169 0.5× 281 1.2× 101 0.6× 29 931
Charles Schick United States 11 425 0.6× 277 0.6× 179 0.5× 412 1.8× 60 0.4× 12 1.0k
Katrina T. Trevor United States 17 754 1.1× 432 0.9× 437 1.3× 99 0.4× 94 0.6× 28 1.4k
G N van Muijen Netherlands 13 472 0.7× 157 0.3× 263 0.8× 267 1.2× 100 0.6× 13 928
Michael Amatangelo United States 15 1.3k 1.9× 189 0.4× 587 1.7× 262 1.1× 94 0.6× 50 1.9k
Roberta Ceruti Italy 15 356 0.5× 198 0.4× 283 0.8× 171 0.8× 115 0.7× 20 806

Countries citing papers authored by Risto Pirinen

Since Specialization
Citations

This map shows the geographic impact of Risto Pirinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risto Pirinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risto Pirinen more than expected).

Fields of papers citing papers by Risto Pirinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risto Pirinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risto Pirinen. The network helps show where Risto Pirinen may publish in the future.

Co-authorship network of co-authors of Risto Pirinen

This figure shows the co-authorship network connecting the top 25 collaborators of Risto Pirinen. A scholar is included among the top collaborators of Risto Pirinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risto Pirinen. Risto Pirinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miinalainen, Ilkka, et al.. (2021). Testis‐Specific Thioredoxins TXNDC2, TXNDC3, and TXNDC6 Are Expressed in Both Testicular and Systemic DLBCL and Correlate with Clinical Disease Presentation. Oxidative Medicine and Cellular Longevity. 2021(1). 8026941–8026941. 2 indexed citations
2.
Nymark, Penny, Mervi Aavikko, Salla Ruosaari, et al.. (2012). Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos‐exposed patients. Molecular Oncology. 7(1). 29–40. 15 indexed citations
3.
Kettunen, Eeva, Mervi Aavikko, Penny Nymark, et al.. (2009). DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure. British Journal of Cancer. 100(8). 1336–1342. 22 indexed citations
4.
Nymark, Penny, Eeva Kettunen, Mervi Aavikko, et al.. (2009). Molecular Alterations at 9q33.1 and Polyploidy in Asbestos-Related Lung Cancer. Clinical Cancer Research. 15(2). 468–475. 12 indexed citations
5.
Pukkila, Matti, Jukka Virtaniemi, Risto Pirinen, et al.. (2009). Reduced γ-Catenin Expression and Poor Survival in Oral Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 135(10). 1035–1035. 13 indexed citations
6.
7.
Määttä, Ann‐Marie, Kimmo Mäkinen, Timo Liimatainen, et al.. (2008). Replication competent Semliki Forest virus prolongs survival in experimental lung cancer. International Journal of Cancer. 123(7). 1704–1711. 36 indexed citations
8.
Pirinen, Risto, et al.. (2006). Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Lung Cancer. 51(3). 313–321. 61 indexed citations
9.
Pirinen, Risto, Kirsi Ropponen, Matti Pukkila, et al.. (2006). CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma. Oral Oncology. 43(1). 51–59. 62 indexed citations
10.
Leinonen, Taina, Risto Pirinen, Jan Böhm, et al.. (2006). Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer. Journal of Clinical Pathology. 60(5). 515–519. 10 indexed citations
11.
Pukkila, Matti, Kirsi Ropponen, Jukka Virtaniemi, et al.. (2006). High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. Journal of Clinical Pathology. 60(3). 267–272. 51 indexed citations
12.
Pirinen, Risto, Jan Böhm, Risto Johansson, et al.. (2004). Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. Human Pathology. 36(1). 44–50. 76 indexed citations
13.
Pirinen, Risto, Raija Tammi, Markku Tammi, et al.. (2001). Prognostic value of hyaluronan expression in non‐small‐cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. International Journal of Cancer. 95(1). 12–17. 6 indexed citations
14.
Pirinen, Risto, Raija Tammi, Markku Tammi, et al.. (2001). Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma. International Journal of Cancer. 95(1). 12–17. 114 indexed citations
15.
16.
Böhm, Jan, Leo Niskanen, Raija Tammi, et al.. (2001). Hyaluronan expression in differentiated thyroid carcinoma. The Journal of Pathology. 196(2). 180–185. 27 indexed citations
17.
Pirinen, Risto, Pasi Hirvikoski, Jan Böhm, et al.. (2000). Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non–small cell lung carcinoma. Human Pathology. 31(9). 1088–1095. 35 indexed citations
18.
Hirvikoski, Pasi, E. Kumpulainen, Jukka Virtaniemi, et al.. (1999). Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. European Journal of Cancer. 35(2). 231–237. 39 indexed citations
19.
Pirinen, Risto, Raija Tammi, Markku Tammi, et al.. (1998). Expression of hyaluronan in normal and dysplastic bronchial epithelium and in squamous cell carcinoma of the lung. International Journal of Cancer. 79(3). 251–255. 28 indexed citations
20.
Pirinen, Risto, P Lipponen, & Karí Syrjänen. (1996). Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.. PubMed. 15(6B). 2835–40. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Noguchi Breakdown of academic impact, for papers by Jason J. Zoeller Breakdown of academic impact, for papers by Karen Sisley Breakdown of academic impact, for papers by Mirva Söderström Breakdown of academic impact, for papers by Mumtaz V. Rojiani Breakdown of academic impact, for papers by Charles Schick Breakdown of academic impact, for papers by Katrina T. Trevor Breakdown of academic impact, for papers by G N van Muijen Breakdown of academic impact, for papers by Michael Amatangelo Breakdown of academic impact, for papers by Roberta Ceruti
Rankless by CCL
2026